VYNE Therapeutics Inc.
- VYNE
- NASDAQ
- Biotechnology
- Immuno-Inflammatory Therapies
- Topical Foam (Dermatology)
- Clinical-Stage Pharma
$28.56
Quote Jul 27, 2026, 08:00 PM UTC
+55.21%over the last month
Max drawdown −15.2%From 1-month high −8.0%3 months +17.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$1.2M
Approximate share count
Next earnings
—
Data unavailable
Analyst target
$5.75
−79.9% from here
Floor
$26.11
8.6% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about VYNEPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
10